[Glutathione in research protocol] [PMID: 12418416] Laboratory literature summary: [Glutathione in research protocol]
Patients should be counseled to contact their healthcare provider if they experience specific warning signs
Reducing dosage and keep dosing frequency would make more sense due to the pk rationale I agree, particularly after several years, once habits regarding exercise, portion control and simply becoming more accustomed to some degree of hunger as being acceptable, I have found this effective
When looking at weight loss thresholds, 78% of patients on tirzepatide achieved at least 15% weight loss, compared to 51% with semaglutide
Patients typically start with a lower dose to minimize Ozempic side effects, gradually increasing to a therapeutic dose (2 mg max dose/week) as directed by the healthcare provider
We help our patients move from wellness to greatness, and live the happier, healthier, and more productive lives they deserve